Medina, Delilah L.
HRN: 21 95 46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFTRIAXONE 1G (VIAL)
10/18/2022
10/24/2022
IV
1g
Q12
Comminuted Fracture, M/3rd, Humerus, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes